Life Sciences Report Collection
Antipsychotic Drugs: Technologies and Global Markets
The global market for antipsychotic drugs should grow from $13.2 billion in 2018 to reach $14.5 billion by 2023 at a compound annual growth rate (CAGR) of 1.9% for the period of 2018-2023.
Mixed Tocopherols: Technologies and Global Markets
The global mixed tocopherols market should reach $5.4 billion by 2023 from $4.3 billion in 2018 at a compound annual growth rate (CAGR) of 4.7% for the period of 2018-2023.
Lysosomal Disease Treatments: Technologies and Global Markets
The global market for lysosomal storage diseases treatment should grow from $5.1 billion in 2018 to reach $7.6 billion by 2023 at a compound annual growth rate (CAGR) of 8.3% for the period of 2018-2023.
Protein Analysis: Subfocus on Oncoproteomics
The global market for protein analysis should grow from $11.6 billion in 2018 to $19.0 billion by 2023 at a compound annual growth rate (CAGR) of 10.4% from 2018 through 2023.
Dental Implants: Global Markets to 2023
The global market for dental implants reached $3.6 billion in 2018 and should reach nearly $5.0 billion by 2023, at a compound annual growth rate (CAGR) of 6.5% for the period of 2018-2023.
Medical Tourism: Market Outlook and Trends
Medical tourism is considered the direct impact of the globalization of healthcare and it has the potential for strong growth globally. It has presented new opportunities and benefits to individuals looking for medical treatment abroad. The medical tourism industry has presented countries with low cost and high-income possibilities leading the countries to plan and develop this section of the tourism industry. Affordability and accessibility of healthcare services offered by medical tourism has spiked the market growth.
Assistive Devices for Special Needs: Technologies and Global Mark...
The global market for assistive devices for special needs reached nearly $15.9 billion in 2018 and should reach $20.1 billion by 2023, at a compound annual growth rate (CAGR) of 4.9% for the period of 2018-2023.
Genetic Modification Therapies Clinical Applications: Gene Thera...
The global market for genetic modification therapies should grow from $2.3 billion in 2018 to reach $17.4 billion by 2023, growing at a compound annual growth rate (CAGR) of 49.9% during the forecast period of 2018-2023.
Next Generation Sequencing for Non-invasive Prenatal Testing: Glo...
The global market for non-invasive prenatal testing (NIPT) should grow from $1.9 billion in 2018 to reach $3.1 billion by 2023, growing at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2018-2023.
The Probiotics Market: Ingredients, Supplements, Foods
The global market for probiotics should grow from $39.2 billion in 2017 to $57.2 billion in 2022, growing at a compound annual growth rate (CAGR) of 7.8% from 2017 through 2022.
Endovascular Treatment Devices: EVAR and TEVAR Emphasis
The global market for endovascular treatment devices reached $2.0 billion in 2017 and should reach nearly $2.8 billion by 2022, at a compound annual growth rate (CAGR) of 7.3% from 2017 to 2022.
Switching to CRISPR-Cas Systems from Uncultivated Microbes
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology is currently the biggest discovery in life science. As a precise gene editing tool, it has been widely used in many areas with a great potential to treat human diseases. While some CRISPR-based therapeutic studies are moving to clinical trials, CRISPR's therapeutic promise was brought into question when some issues were found that could become major obstacles in moving the great genome editing tools to the clinic.While many groups are actively resolving these obstacles, the significant challenges to minimize the immunological risks and avoid potential tumorgenicity have received more attention as big concerns for CRISPR-Cas therapeutics advancing toward the clinic. We believe it is timely to summarize and analyze the emerging immunological risk and potential tumorgenicity with the CRISPR-Cas systems, to predict how this exciting genome editing market will affect other related segments of the entire life science market in the next few years. We also hope our opinion could serve as a "crowd crystal" on those discussions in response to the issues, and bring a better market environment for the technology to be sharpened and advanced into clinical applications.
Biosensors and Nanosensors: Global Markets and Technologies
The global market for biosensors and nanosensors should grow from $21.1 billion in 2018 to reach $31.9 billion by 2023, growing at a compound annual growth rate (CAGR) of 8.6% during the forecast period of 2018-2023.
Adoptive Transfer of Autologous Lymphocytes Targeting Somatically...
Adoptive Cell Therapies (ACTs) and the infusion of autologous or redirected tumor-specific T-cells have the potential to drastically impact the treatment of a variety of cancers, especially common epithelial cancers. This report summarizes the current state of clinical research and trials, explains the impact of ACTs on the treatment of several metastasized malignancies, and also raises important concerns about the scalability and compatibility of TILs.
Antiemetics: Technologies and Global Markets
The global market for antiemetics reached $4.1 billion in 2017 and should reach $5.9 billion by 2022, at a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2018-2023.
Immunohistochemistry (IHC): Global Markets to 2022
The global immunohistochemistry market totaled $1.6 billion in 2017 and is estimated to reach $2.3 billion by 2022, growing at a compound annual growth rate (CAGR) of 7.8% for the period of 2017-2022.
Cognition and Memory Enhancement Drugs: Technologies and Global M...
The global cognition and memory-enhancing drugs market should reach over $4.2 billion by 2022 from $2.8 billion in 2017 at a compound annual growth rate (CAGR) of 8.7% for the period 2017-2022.
Nutraceuticals: Global Markets to 2023
The global nutraceutical market should reach $336.1 billion by 2023 from $230.9 billion in 2018 at a compound annual growth rate (CAGR) of 7.8%, from 2018 to 2023.
Microfluidics: Technologies and Global Markets
The global market for microfluidic technologies reached $6.8 billion in 2017 and should reach nearly $13.9 billion by 2022, at a compound annual growth rate (CAGR) of 15.3% for the period of 2017-2022.
Neuroprotective Agents: Therapeutic Applications and Global Marke...
The global market for neuroprotective agents will grow from $54.4 billion in 2017 to $75.8 billion by 2022 with a compound annual growth rate (CAGR) of 6.8% for the period of 2017-2022.
Biopesticides: Global Markets to 2022
The global market for synthetic and biopesticides should reach $79.3 billion by 2022 from $61.2 billion in 2017 at a compound annual growth rate (CAGR) of 5.3% during 2017-2022.
Antiulcerant Drugs: Global Markets to 2022
The global antiulcerant drugs market will grow from $33.0 billion in 2017 to $37.4 billion by 2022 with a compound annual growth rate (CAGR) of 2.5% for the period of 2017-2022.
The Chinese Market for DNA Sequencing
The Chinese market for DNA sequencing totaled $1.2 billion in 2017. The market should total $2.9 billion by 2022, growing at a compound annual growth rate (CAGR) of 19.0% during 2017-2022.
Single Blood Drop Analysis: Technologies and Global Market
The global market for single blood drop analysis will grow from $9.2 billion in 2017 to $25.1 billion by 2022 with a compound annual growth rate (CAGR) of 10.6% for the period of 2017-2022.
The Global Influenza Market
The global influenza market was valued at nearly $5.6 billion in 2017 and is expected to reach nearly $6.5 billion by 2022, increasing at a compound annual growth rate (CAGR) of 3.0% from 2017 through 2022.
